Abstract
OBJECTIVE: Mental distress may entail increased risk of hip fracture, but it is uncertain whether the effect consists solely of an indirect effect through use of medication, or whether it is also mediated through other mechanism. The purpose of this study was to examine the association between mental distress and risk of hip fracture in women, adjusted for medication (that is, use of tranquillisers/sedatives or hypnotics). DESIGN: A three year follow up of hip fracture was conducted on 18,612 women, consisting of 92.5% of all women aged 50 years or older in a Norwegian county. Three hundred and twenty nine suffered a hip fracture. A mental distress index was based on questions about life dissatisfaction, nervousness, loneliness, sleep disorders, troubled and uneasy feelings, depression and impairment attributable to psychological complaints. Relative risk with 95% confidence intervals (CI) of hip fracture with respect to mental distress were controlled for medication, age, body mass index (BMI), smoking, physical inactivity, and physical illness by means of Cox regression. RESULTS: The 10% of women with the highest mental distress had more than twofold increased risk of hip fracture compared with the 10% of women with the lowest mental distress, after adjustment for age and medication. The relative risk was 1.95 (95% CI 1.2, 3.3) after additional control for BMI, smoking, physical inactivity, and physical illness. The relative risk of hip fracture for daily users of medication compared with never users was 2.1 (95% CI 1.6, 2.9). After adjusting for mental distress it was 1.5 (95% CI 1.0, 2.2). CONCLUSIONS: Risk of hip fracture was positively related to mental distress, also after adjustment for medication use. The effect of tranquillisers/sedatives or hypnotics on hip fracture risk may be overestimated in studies with no adjustments for mental distress.
Full Text
The Full Text of this article is available as a PDF (102.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cumming R. G., Klineberg R. J. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust. 1993 Mar 15;158(6):414–417. doi: 10.5694/j.1326-5377.1993.tb121839.x. [DOI] [PubMed] [Google Scholar]
- Cummings S. R., Nevitt M. C., Browner W. S., Stone K., Fox K. M., Ensrud K. E., Cauley J., Black D., Vogt T. M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995 Mar 23;332(12):767–773. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
- Dargent-Molina P., Favier F., Grandjean H., Baudoin C., Schott A. M., Hausherr E., Meunier P. J., Bréart G. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996 Jul 20;348(9021):145–149. doi: 10.1016/s0140-6736(96)01440-7. [DOI] [PubMed] [Google Scholar]
- Derogatis L. R., Lipman R. S., Rickels K., Uhlenhuth E. H., Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974 Jan;19(1):1–15. doi: 10.1002/bs.3830190102. [DOI] [PubMed] [Google Scholar]
- Forsén L., Bjartveit K., Bjørndal A., Edna T. H., Meyer H. E., Schei B. Ex-smokers and risk of hip fracture. Am J Public Health. 1998 Oct;88(10):1481–1483. doi: 10.2105/ajph.88.10.1481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forsén L., Bjørndal A., Bjartveit K., Edna T. H., Holmen J., Jessen V., Westberg G. Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture. J Bone Miner Res. 1994 Nov;9(11):1671–1678. doi: 10.1002/jbmr.5650091102. [DOI] [PubMed] [Google Scholar]
- Grisso J. A., Kelsey J. L., Strom B. L., Chiu G. Y., Maislin G., O'Brien L. A., Hoffman S., Kaplan F. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991 May 9;324(19):1326–1331. doi: 10.1056/NEJM199105093241905. [DOI] [PubMed] [Google Scholar]
- Herings R. M., Stricker B. H., de Boer A., Bakker A., Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med. 1995 Sep 11;155(16):1801–1807. [PubMed] [Google Scholar]
- Holmen J., Midthjell K., Forsén L., Skjerve K., Gorseth M., Oseland A. Helseundersøkelsen i Nord-Trøndelag 1984-86. Fremmøtet og sammenlikning av dem som møtte og dem som ikke møtte. Tidsskr Nor Laegeforen. 1990 Jun 10;110(15):1973–1977. [PubMed] [Google Scholar]
- Klein G. L., Herndon D. N., Goodman W. G., Langman C. B., Phillips W. A., Dickson I. R., Eastell R., Naylor K. E., Maloney N. A., Desai M. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995 Nov;17(5):455–460. doi: 10.1016/8756-3282(95)00279-1. [DOI] [PubMed] [Google Scholar]
- Mendelson W. B. The use of sedative/hypnotic medication and its correlation with falling down in the hospital. Sleep. 1996 Nov;19(9):698–701. [PubMed] [Google Scholar]
- Meyer H. E., Henriksen C., Falch J. A., Pedersen J. I., Tverdal A. Risk factors for hip fracture in a high incidence area: a case-control study from Oslo, Norway. Osteoporos Int. 1995;5(4):239–246. doi: 10.1007/BF01774013. [DOI] [PubMed] [Google Scholar]
- Michelson D., Stratakis C., Hill L., Reynolds J., Galliven E., Chrousos G., Gold P. Bone mineral density in women with depression. N Engl J Med. 1996 Oct 17;335(16):1176–1181. doi: 10.1056/NEJM199610173351602. [DOI] [PubMed] [Google Scholar]
- Naess S., Midthjell K., Moum T., Sørensen T., Tambs K. Diabetes mellitus and psychological well-being. Results of the Nord-Trøndelag health survey. Scand J Soc Med. 1995 Sep;23(3):179–188. doi: 10.1177/140349489502300308. [DOI] [PubMed] [Google Scholar]
- Neutel C. I., Hirdes J. P., Maxwell C. J., Patten S. B. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996 Jul;25(4):273–278. doi: 10.1093/ageing/25.4.273. [DOI] [PubMed] [Google Scholar]
- Ray W. A., Griffin M. R., Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989 Dec 15;262(23):3303–3307. [PubMed] [Google Scholar]
- Swolin D., Brantsing C., Matejka G., Ohlsson C. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol. 1996 Jun;149(3):397–403. doi: 10.1677/joe.0.1490397. [DOI] [PubMed] [Google Scholar]
- Tambs K., Moum T. Low genetic effect and age-specific family effect for symptoms of anxiety and depression in nuclear families, halfsibs and twins. J Affect Disord. 1993 Mar;27(3):183–195. doi: 10.1016/0165-0327(93)90006-6. [DOI] [PubMed] [Google Scholar]